HHS, DOD invest to expand U.S. COVID-19 test production
The departments of Health and Human Services and Defense this weekend announced a pair of contracts to expand domestic COVID-19 testing capacity. HHS and DOD awarded to Hologic, Inc. $119 million to expand the supplier’s production capacity for COVID-19 tests made at facilities in Wisconsin, Maine and California.
The funds are expected to increase Hologic’s production capacity to 13 million tests per month by January 2022.
The agencies also announced a $12.7 million contract with InBios International, Inc., to expand production of two rapid point-of-care SARS-CoV-2 tests. The funds will enable InBios to reach a production capacity of 400,000 units per week by May 2021.
Related News Articles
Blog
The RAND Corporation recently released the fifth iteration of its biannual hospital price report. The AHA has previously highlighted significant flaws with…
Headline
Adults age 65 and older are encouraged to receive an updated dosage of the COVID-19 vaccine, the Centers for Disease Control and Prevention announced April 25…
Headline
The Pfizer and Moderna COVID-19 vaccines can cause myocarditis, but do not appear to cause infertility, Guillain-Barré syndrome, Bell’s palsy, thrombosis with…
Headline
The Food and Drug Administration recently granted emergency use authorization for the first over-the-counter home antigen test to detect both flu and COVID-19…
Headline
Centers for Disease Control and Prevention Director Mandy Cohen, M.D., Feb. 28 endorsed a recommendation by its Advisory Committee on Immunization Practices…
Headline
Paxlovid may no longer be distributed with an emergency use label after March 8, the Food and Drug Administration announced. Providers may dispense unexpired…